228 related articles for article (PubMed ID: 20368795)
1. Molecular profiling of endometrial malignancies.
Samarnthai N; Hall K; Yeh IT
Obstet Gynecol Int; 2010; 2010():162363. PubMed ID: 20368795
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
Lax SF
Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
[TBL] [Abstract][Full Text] [Related]
3. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
Lax SF
Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
[TBL] [Abstract][Full Text] [Related]
4. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
5. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.
Hrzenjak A; Moinfar F; Tavassoli FA; Strohmeier B; Kremser ML; Zatloukal K; Denk H
J Mol Diagn; 2005 Aug; 7(3):388-95. PubMed ID: 16049311
[TBL] [Abstract][Full Text] [Related]
6. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
7. JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma.
Amador-Ortiz C; Roma AA; Huettner PC; Becker N; Pfeifer JD
Hum Pathol; 2011 Jul; 42(7):939-46. PubMed ID: 21316079
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.
Huang HY; Ladanyi M; Soslow RA
Am J Surg Pathol; 2004 Feb; 28(2):224-32. PubMed ID: 15043312
[TBL] [Abstract][Full Text] [Related]
9. Mixed and Ambiguous Endometrial Carcinomas: A Heterogenous Group of Tumors With Different Clinicopathologic and Molecular Genetic Features.
Espinosa I; D'Angelo E; Palacios J; Prat J
Am J Surg Pathol; 2016 Jul; 40(7):972-81. PubMed ID: 26975040
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X
J Clin Pathol; 2009 Sep; 62(9):777-85. PubMed ID: 18977806
[TBL] [Abstract][Full Text] [Related]
11. [Values of JAZF1 gene rearrangement detected by fluorescence in-situ hybridization in diagnosis of endometrial stromal tumours].
Bai QM; Chang B; Tu XY; Bi R; Cheng YF; Huang D; Zhu XL; Wu LJ; Zhang X; Zhou XY; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):769-774. PubMed ID: 29136690
[No Abstract] [Full Text] [Related]
12. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases.
Kurihara S; Oda Y; Ohishi Y; Iwasa A; Takahira T; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1228-38. PubMed ID: 18580489
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J
Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
[TBL] [Abstract][Full Text] [Related]
15. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
Lax SF
Virchows Arch; 2004 Mar; 444(3):213-23. PubMed ID: 14747944
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X
Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921
[TBL] [Abstract][Full Text] [Related]
18. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
[TBL] [Abstract][Full Text] [Related]
19. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
Shih IeM; Kurman RJ
Am J Pathol; 2004 May; 164(5):1511-8. PubMed ID: 15111296
[TBL] [Abstract][Full Text] [Related]
20. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
